Effects of dahuangzhechong pills on cytokines and mitogen activated protein kinase activation in rats with hepatic fibrosis

Journal of Ethnopharmacology

Volumn 132, Issue 1, 2010, Pages 157-164

  Cai, Hong Bing ^a   Sun, Xue Gang ^a   Liu, Zhi Feng ^b   Liu, Ya Wei ^a   Tang, Jing ^a   Liu, Qiang ^a   Ji, Bao Min ^c   Song, Yu Hong ^a   Zhou, Ying Chun ^a   Yang, Ming Hui ^c   Lv, Zhi Ping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Cytokine; Dahuangzhechong pill; Hepatic fibrosis; Mitogen activated protein kinase

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; CHINESE DRUG; COLCHICINE; COLLAGEN TYPE 4; DAHUANGZHECHONG; FUFANG BIEJIA RUANGAN PIAN; HYALURONIC ACID; INTERLEUKIN 13; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROCOLLAGEN; PROCOLLAGEN TYPE 3; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHINESE MEDICINE; CYTOKINE RELEASE; DOSE RESPONSE; DRUG ACTIVITY; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LOW DRUG DOSE; MALE; NONHUMAN; PILL; PROTEIN EXPRESSION; RAT;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CYTOKINES; DOWN-REGULATION; DRUGS, CHINESE HERBAL; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TESTS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS;

RATTUS;

EID: 77957791564     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.08.019     Document Type: Article

References (49)

1. Bahçecioĝlu I.H., Yalniz M., Ataseven H., Bülbüller N., Keçeci M., Demirdaĝ K., Ozercan I., Ustündaĝ B. TNF-alpha and leptin in experimental liver fibrosis models induced by carbon tetrachloride and by common bile duct ligation. Cell Biochemistry and Function 2004, 22:359-363.
2. 2-dependent MAPK pathways. Journal of Cellular Biochemistry 2006, 97:188-197.
3. Cheng M.H., Pan Z.H., Rao G.H., Xu J.H., Zhang F., Chen W.Z., Mo C.J. Evaluation of hepatocellular function influenced by Chinese drug Dahuangzhechong pill. Zhongguo Zhong Yao Za Zhi 2008, 33:564-566.
4. Chiaramonte M.G., Cheever A.W., Malley J.D., Donaldson D.D., Wynn T.A. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 2001, 34:273-282.
5. Chinese Association of Integrative Medicine, Liver Disease Committee Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine. Zhong Xi Yi Jie He Xue Bao 2006, 4:551-555.
6. (4)-induced fibrogenesis via inhibition of hepatic stellate cells activation. World Journal of Gastroenterology 2009, 15:4753-4762.
7. Fang H.L., Lai J.T., Lin W.C. Inhibitory effect of olive oil on fibrosis induced by carbon tetrachloride in rat liver. Clinical Nutrition 2008, 27:900-907.
8. Gressner O.A., Weiskirchen R., Gressner A.M. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clinica Chimica Acta 2007, 381:107-113.
9. Han Y.L., Li Z.W. Purification and activity calculated of fibrinolytic factors from Eupolyphaga sinensis. Zhong Yao Cai 2006, 29:765-767.
10. Hattori S., Dhar D.K., Hara N., Tonomoto Y., Onoda T., Ono T., Yamanoi A., Tachibana M., Tsuchiya M., Nagasue N. FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2. Laboratory Investigation 2007, 87:591-601.
11. Henderson N.C., Pollock K.J., Frew J., Mackinnon A.C., Flavell R.A., Davis R.J., Sethi T., Simpson K.J. Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 2007, 56:982-990.
12. Inao M., Mochida S., Matsui A., Eguchi Y., Yulutuz Y., Wang Y., Naiki K., Kakinuma T., Fujimori K., Nagoshi S., Fujiwara K. Japanese medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. Journal of Hepatology 2004, 41:584-591.
13. Jia Y., Niu Y.C., Zhang Y.B., Zhou L., Dong M.X. Effect of hirudin on the expression of CTGF mRNA in fibrotic liver in rats. Lishizhen Medicine and Materia Medica Research 2009, 20:95-97.
14. Jiang Y., Xu J., Zhou C., Wu Z., Zhong S., Liu J., Luo W., Chen T., Qin Q., Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. American Journal of Respiratory and Critical Care Medicine 2005, 171:850-857.
15. Jinnin M., Ihn H., Yamane K., Tamaki K. Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts. The Journal of Biological Chemistry 2004, 279:41783-41791.
16. Kaviratne M., Hesse M., Leusink M., Cheever A.W., Davies S.J., McKerrow J.H., Wakefield L.M., Letterio J.J., Wynn T.A. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. Journal of Immunology 2004, 173:4020-4029.
17. Li J., Hu W., Baldassare J.J., Bora P.S., Chen S., Poulos J.E., O'Neill R., Britton R.S., Bacon B.R. The ethanol metabolite, linolenic acid ethyl ester, stimulates mitogen-activated protein kinase and cyclin signaling in hepatic stellate cells. Life Science 2003, 73:1083-1096.
18. Li L., Xu M., Liu Z.L. Effect of dahuangzhechong pill on transforming growth factor-beta 1 in hepatic stellate cells in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003, 23:763-766.
19. Li R.L., Ma Y., Wei W., Ye G.S., Chen W.B., Yan J.C. Pharmacological effects of total glucosides from paeony root on CC14-induced liver fibrosis and function of hepatic stellate cells. Chinese Journal of New Drugs 2007, 16:685-689.
20. 4-induced liver fibrosis in rats. Food and Chemical Toxicology 2006, 44:336-343.
21. Luster M.I., Simeonova P.P., Gallucci R.M., Bruccoleri A., Blazka M.E., Yucesoy B. Role of inflammation in chemical-induced hepatotoxicity. Toxicology Letters 2001, 120:317-321.
22. Martinez-Hernandez A., Delgado F.M., Amenta P.S. The extracellular matrix in hepatic regeneration. Localization of collagen types I, III, IV, laminin and fibronectin. Laboratory Investigation 1991, 64:157-166.
23. Nan J.X., Park E.J., Kim Y.C., Ko G., Sohn D.H. Scutellaria baicalensis inhibits liver fibrosis induced by bile duct ligation or carbon tetrachloride in rats. The Journal of Pharmacy and Pharmacology 2002, 54:555-563.
24. Nissen N.N., Martin P. Hepatocellular carcinoma: the high risk patient. Journal of Clinical Gastroenterology 2002, 35:S79-S85.
25. Oh W.Y., Pyo S., Lee K.R., Lee B.K., Shin D.H., Cho S.I., Lee S.M. Effect of Holotrichia diomphalia larvae on liver fibrosis and hepatotoxicity in rats. Journal of Ethnopharmacology 2003, 87:175-180.
26. Okita K., Sakaida I., Hino K. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology 2002, 62:24-28.
27. O'Sullivan A.W., Wang J.H., Redmond H.P. The role of P38 MAPK and PKC in BLP induced TNF-alpha release, apoptosis, and NFkappaB activation in THP-1 monocyte cells. The Journal of Surgical Research 2009, 151:138-144.
28. Padhy B.M., Srivastava A., Kumar V.L. Calotropis procera latex affords protection against carbon tetrachloride induced hepatotoxicity in rats. Journal of Ethnopharmacology 2007, 113:498-502.
29. Pan Z.H., Xie Y., He H.W. Effects of dahuangzhechong pill on expression and activity of matrix metalloproteinase in rats' hepatic stellate cells. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005, 25:1100-1103.
30. Park E.J., Zhao Y.Z., Lian L., Kim Y.C., Sohn D.H. Skullcapflavone I from Scutellaria baicalensis induces apoptosis in activated rat hepatic stellate cells. Planta Medica 2005, 71(9):885-887.
31. Parsons C.J., Takashima M., Rippe R.A. Molecular mechanisms of hepatic fibrogenesis. Journal of Gastroenterology and Hepatology 2007, 22:S79-S84.
32. Peng Q., Matsuda T., Hirst S.J. Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle. American Journal of Respiratory and Critical Care Medicine 2004, 169:596-603.
33. Qiang H., Lin Y., Zhang X., Zeng X., Shi J., Chen Y.X., Yang M.F., Han Z.G., Xie W.F. Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver International 2006, 26:1126-1137.
34. Ramadori G., Zöhrens G., Manns M., Rieder H., Dienes H.P., Hess G., Meyer K.H., Büschenfelde Z. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. European Journal of Clinical Investigation 1991, 21:323-330.
35. Roberts R.A., James N.H., Cosulich S., Hasmall S.C., Orphanides G. Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?. Toxicology Letters 2001, 120:301-306.
36. Schiavon L.L., Narciso-Schiavon J.L., Carvalho Filho R.J., Sampaio J.P., Medina-Pestana J.O., Lanzoni V.P., Silva A.E., Ferraz M.L. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis 2008, 15:666-674.
37. Schneider M., Voss B., Högemann B., Eberhardt G., Gerlach U. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. Hepatogastroenterology 1989, 36:506-510.
38. Shibata H., Yoshioka Y., Ohkawa A., Abe Y., Nomura T., Mukai Y., Nakagawa S., Taniai M., Ohta T., Mayumi T., Kamada H., Tsunoda S., Tsutsumi Y. The therapeutic effect of TNFR1-selective antagonistic mutant TNF-alpha in murine hepatitis models. Cytokine 2008, 44:229-233.
39. Simeonova P.P., Gallucci R.M., Hulderman T., Wilson R., Kommineni C., Rao M., Luster M.I. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicology and Applied Pharmacology 2001, 177:112-120.
40. Sun K., Chen X., Liu W., Chen N., Chu Y., Xie F. Experimental study of dahuangzhechong pills in the treatment of immunological liver fibrosis in rats. Zhongguo Zhong Yao Za Zhi 1998, 23:497-499.
41. Tan Y., Lv Z.P., Bai X.C., Liu X.Y., Zhang X.F. Traditional Chinese medicine Bao Gan Ning increase phosphorylation of CREB in liver fibrosis in vivo and in vitro. Journal of Ethnopharmacology 2006, 105:69-75.
42. Thompson K., Maltby J., Fallowfield J., McAulay M., Millward-Sadler H., Sheron N. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 1998, 28:1597-1606.
43. Westra J., Doornbos-van der Meer B., de Boer P., van Leeuwen M.A., van Rijswijk M.H., Limburg P.C. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Arthritis Research and Therapy 2004, 6:R384-392.
44. Wells R.G. Mechanisms of liver fibrosis: new insights into an old problem. Drug Discovery Today: Disease Mechanisms 2006, 3:489-495.
45. Xie S.B., Yao J.L., Zheng R.Q., Peng X.M., Gao Z.L. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary and Pancreatic Diseases International 2003, 2:69-72.
46. Zhan Y., Li M.D., Wei M.H., Wang Z., Huang X., Xu Q., Lu H. Emodin on hepatic fibrosis in rats. Chinese Medical Journal 2000, 113:599-601.
47. Zhang Y.H., Liu J.T., Wen B.Y., Xiao X.H. In vitro inhibition of proliferation of vascular smooth muscle cells by serum of rats treated with dahuangzhechong pill. Journal of Ethnopharmacology 2007, 112:375-379.
48. Zhang B.J., Xu D., Guo Y., Ping J., Chen L.B., Wang H. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clinical and Experimental Pharmacology and Physiology 2008, 35:303-309.
49. Zhang Y.H., Liu J.T., Wen B.Y., Liu N. Mechanisms of inhibiting proliferation of vascular smooth muscle cells by serum of rats treated with dahuangzhechong pill. Journal of Ethnopharmacology 2009, 124:125-129.